Furthermore, VPA promoted the activation of the Wnt signaling pathway in the hippocampus and increased the expression of the procedural Wnt target gene NeuroD1, potentially suggesting that VPA is a promising therapeutic approach for AD prevention and treatment. Here, NEUROD1 is linked to Alzheimer disease.